First Trust Advisors LP Puma Biotechnology, Inc. Transaction History

First Trust Advisors LP

  • $101 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 04, 2019
SELL
$8.75 - $12.85 $446,136 - $655,182
-50,987 Closed
0 $0
Q2 2019

Jul 30, 2019
BUY
$12.3 - $35.76 $627,140 - $1.82 Million
50,987 New
50,987 $648,000
Q4 2017

Feb 08, 2018
SELL
$93.85 - $132.45 $430,396 - $607,415
-4,586 Closed
0 $0
Q3 2017

Oct 24, 2017
BUY
$72.0 - $119.75 $330,192 - $549,173
4,586
4,586 $549,000

Others Institutions Holding PBYI

# of Institutions
102
Shares Held
29.1M
Call Options Held
60.6K
Put Options Held
16.3K
View Full List

About PUMA BIOTECHNOLOGY, INC.

PBYI Quotes by TradingView
  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $132M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email